iris versicolor boiron 4ch globuli
boiron - iris versicolor 4ch 1 % - globuli - 4ch - iris versicolor 4ch 1 %
iris versicolor boiron 5ch globuli
boiron - iris versicolor 5ch 1 % - globuli - 5ch - iris versicolor 5ch 1 %
iris versicolor boiron 7ch globuli
boiron - iris versicolor 7ch 1 % - globuli - 7ch - iris versicolor 7ch 1 %
iris versicolor boiron 9ch globuli
boiron - iris versicolor 9ch 1 % - globuli - 9ch - iris versicolor 9ch 1 %
iris versicolor boiron 30k globuli
boiron - iris versicolor 30k 1 % - globuli - 30k - iris versicolor 30k 1 %
iris versicolor boiron 200k globuli
boiron - iris versicolor 200k 1 % - globuli - 200k - iris versicolor 200k 1 %
iris versicolor boiron 200k globuli verp. éénmalig gebr.
boiron - iris versicolor 200k 1 % - globuli in verpakking voor éénmalig gebruik - 200k - iris versicolor 200k 1 %
iris versicolor boiron mk globuli verp. éénmalig gebr.
boiron - iris versicolor mk 1 % - globuli in verpakking voor éénmalig gebruik - mk - iris versicolor mk 1 %
lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochloride - colorectale neoplasma's - antineoplastische middelen - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.